MedPath

probiotics and polycistic ovary syndrome wome

Not Applicable
Conditions
Polycystic Ovarian Syndrome.
Sclerocystic ovary syndrome
Registration Number
IRCT2013081111763N11
Lead Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
72
Inclusion Criteria

Women with polycystic ovarian syndrome (based on Rotterdam criteria), aged 15 to 40, lack of smoking or drinking alcohol, lack of chronic heart, kidney, liver, lung or pancreatic specially endocardic diseases, thyroid disorder, small bowel syndrome, autoimmune disease, lack of allergy to probiotic capsules or placebo, not use of chemotherapy drugs (tamoxifen), corticosteroid (insulin injection, statins, diuretics) antibiotic and multivitamin mineral supplements and omega-3. Exclusion criteria: incidence of diseases mentioned above, use of multivitamin mineral supplement.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath